Mastering chronic total occlusions PCI: Unpack the data, indications, best practices and controversies in chronic total occlusion (CTO) interventions, with a focus on Veterans Health Administration ...

Learn and stay certified — all in one program: The CMP blends continuous learning with assessment, making it an efficient, effective way to grow your expertise while maintaining your credentials.

Understand and strategically utilize the new program signaling feature for the 2026 Cardiovascular Fellowship MyERAS® application season. Join ACC's Program Directors and Graduate Medical Educators ...

Withdrawal of other heart failure treatment while maintaining carvedilol as a single therapy did not worsen left ventricular (LV) function compared to usual treatment at 52 weeks in patients with ...

“Courtside with the Chair” is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this ...

Tap into the ultimate resource on adult congenital heart disease (ACHD) with ACC's new ACHD Self-Assessment Program (SAP). The just-launched program provides comprehensive video-based learning, expert ...

A multi-center cohort study of patients in China with arrhythmogenic cardiomyopathy (ACM) is contributing important insights into understanding the disease and the unique genetic and clinical ...

Taking antihypertensive medications at bedtime rather than in the morning is safe for adults with hypertension in primary care and for frail older nursing home patients, but it does not reduce ...

A fixed-dose combination therapy of obicetrapib plus ezetimibe was found to significantly reduce LDL-C in patients with preexisting or at high risk for developing atherosclerotic cardiovascular ...

Learn best practices and emerging science across practice-changing topics in care, including cardiac arrhythmias, cardiovascular disease prevention, heart failure and cardiomyopathies and vascular ...

The dual GIP/GLP-1 receptor agonist tirzepatide is effective in improving cardiometabolic abnormalities and resolving metabolic syndrome (MetS) in patients with type 2 diabetes (T2D) compared to ...

Studies exploring the association between vutrisiran and all-cause mortality and the prognostic information gleaned from serum transthyretin (sTTR) levels in patients with transthyretin amyloid ...